Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

But that doesn’t appear to hinder the effectiveness of immunotherapy for cancer in seniors, a new study says. Seniors with ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

It is a cancer drug her company discovered—one that has made her the face of a rising pharmaceutical star. When Xia founded ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

MONDAY, April 21, 2025 (HealthDay News) — Immunotherapy might help keep lung cancer at bay for months or even years after the ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

The global glioblastoma treatment drugs market is on the cusp of transformative growth. With market revenues expected to surge from approximately USD 844.8 million in 2025 to a projected USD 1,470.5 ...